India Launches World‑First Clinical Study Evaluating Ayurveda as Adjunct to TB Treatment – Dr Jitendra Singh

India’s First Global Clinical Study on Ayurveda‑Adjunct TB Treatment On World Tuberculosis Day 2026, the Union Minister of State (Independent Charge) for Science & Technology, Dr Jitendra Singh , announced a landmark clinical trial that will, for the first time globally, evaluate Ayurveda as an adjunct to standard ATT . The study aims to improve patient outcomes, nutrition, and quality of life while generating scientific evidence for integrative care. Key Developments Collaboration between the DBT and the Ministry of Ayush. Enrollment of 1,250 newly diagnosed TB patients across eight premier institutions. Evaluation parameters: body weight, nutritional status, disease progression, quality of life, safety and tolerability. Use of advanced tools – DEXA, MRI, immune profiling, metabolomics, and single‑cell RNA sequencing – to study TB‑associated cachexia. Integration with existing programmes such as the NTEP and the RePORT India network. Important Facts India accounts for roughly 25 % of the global TB burden . The incidence fell to 187 cases per 100,000 population in 2024 , a 21 % decline since 2015, reflecting the impact of intensified diagnostics, digital adherence technologies, and patient‑centric care under NTEP. However, challenges persist: drug‑related toxicity, undernutrition, immune suppression, post‑cure pulmonary impairment, and the rising threat of drug‑resistant TB . The study also builds on the 32,000 Mycobacterium tuberculosis strains to inform drug discovery and resistance monitoring (GS3: Health)">InTGS Consortium , which has created a national genomic repository to support diagnostics and containment strategies. UPSC Relevance Understanding this initiative touches multiple UPSC syllabus areas: Health sector reforms (GS3) , the role of traditional knowledge systems in modern policy (GS4) , and the importance of inter‑ministerial coordination (GS2: Polity) . The case exemplifies how scientific validation of indigenous systems can be leveraged for public health, a recurring theme in ethics and governance questions. Way Forward The Ministry urges a ‘whole‑of‑nation’ effort: community awareness to reduce stigma, nutritional support, and lifestyle interventions alongside drug therapy. Successful outcomes could lead to policy incorporation of Ayurveda‑based supportive care in the NTEP, set a precedent for integrative research, and strengthen India’s position as a global leader in TB elimination.